ICON (ICLR) vs MDxHealth SA (MDXH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
ICON (ICLR) has outperformed MDxHealth SA (MDXH) over the past year, losing 11.8% versus a loss of 87.2%. ICON is the larger company by market cap ($12.69 billion vs $55.4 million), about 229.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ICLR | MDXH |
|---|---|---|
| Share price | $164.50 | $0.5805 |
| Market cap | $12.69B | $55.39M |
| 1-day change | +0.26% | -3.22% |
| YTD return | -9.72% | -83.74% |
| 1-year return | -11.79% | -87.16% |
| 5-year return | -40.19% | — |
| P/E ratio (TTM) | 173.16 | — |
| Forward P/E | 13.93 | — |
| EPS (TTM) | $0.95 | $-0.70 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $8.25B | — |
| Revenue growth (YoY) | +0.76% | — |
| Net income (latest FY) | $229.34M | — |
| Gross margin | 26.37% | — |
| Operating margin | 5.37% | — |
| Net margin | 2.78% | — |
| 52-week high | $203.91 | $5.33 |
| 52-week low | $66.57 | $0.40 |
| Distance from 52-week high | -19.33% | -89.11% |
| Analyst consensus | buy | none |
| Avg. price target upside | +12.10% | +210.08% |
| Average volume | 822.57K | 5.69M |
| Shares outstanding | 77.15M | 95.42M |
| Employees | 40,200 | 364 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ICON is about 229.1 times larger than MDxHealth SA by market value ($12.69B vs $55.39M).
- ICLR has outperformed MDXH by 75.4 percentage points over the past year.
About ICON
ICLR stock →ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 40,200 employees
About MDxHealth SA
MDXH stock →MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and Resolve mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.
Health Care · Medical Specialities · 364 employees
ICLR vs MDXH FAQ
Which is bigger, ICON or MDxHealth SA?
ICON (ICLR) is larger, with a market capitalization of $12.69B compared with $55.39M for MDxHealth SA (MDXH).
Which stock has performed better over the past year, ICLR or MDXH?
ICLR returned -11.79% over the past 12 months, compared with -87.16% for MDXH (price return, excluding dividends). Past performance does not predict future results.
Are ICON and MDxHealth SA in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Commercial Physical & Biological Resarch for ICON and Medical Specialities for MDxHealth SA.